Ligand Pharmaceuticals
LGND
#4177
Rank
S$2.77 B
Marketcap
$143.98
Share price
2.17%
Change (1 day)
49.34%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.08

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.09. In 2022 the company made an earnings per share (EPS) of -$2.64 a decrease over its 2021 EPS that were of $4.61.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.08-178.77%
2022-$2.64-157.23%
2021$4.61-2571.43%
2020-$0.19-100.46%
2019$40.77353.48%
2018$8.991025%
2017$0.80-700%
2016-$0.13-100.87%
2015$15.401859.32%
2014$0.795.36%
2013$0.758.0704505322479E+18%
2012$0.0000000000-100%
2011$0.65-194.23%
2010-$0.69548.38%
2009-$0.11-98.7%
2008-$8.23-136.52%
2007$22.54-787.8%
2006-$3.28-14.58%
2005-$3.84-21.31%
2004-$4.88-55.15%
2003-$10.8781.33%
2002-$5.992.74%
2001-$5.83-45.93%
2000-$10.79-14.56%
1999-$12.63-45.52%
1998-$23.18-3.97%
1997-$24.14132.31%
1996-$10.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.85 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.66 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.43 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.48 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.23 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.29 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.82 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.76 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA